HOYA Corporation (HOCPY)
USD 109.01
(1.78%)
USD 109.01
(1.78%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 353.8 Billion JPY | 41.15% |
| 2022 | 210.16 Billion JPY | 4.59% |
| 2021 | 200.94 Billion JPY | 22.58% |
| 2020 | 163.93 Billion JPY | 10.97% |
| 2019 | 147.71 Billion JPY | 0.91% |
| 2018 | 146.39 Billion JPY | -48.12% |
| 2017 | 282.18 Billion JPY | 12.73% |
| 2016 | 250.31 Billion JPY | -1.65% |
| 2015 | 254.52 Billion JPY | 8.03% |
| 2014 | 235.6 Billion JPY | 23.64% |
| 2013 | 190.54 Billion JPY | 10.77% |
| 2012 | 172.02 Billion JPY | 8.1% |
| 2011 | 159.13 Billion JPY | -2.18% |
| 2010 | 162.67 Billion JPY | 154.54% |
| 2009 | 63.91 Billion JPY | 8.15% |
| 2008 | 59.09 Billion JPY | -37.84% |
| 2007 | 95.07 Billion JPY | -11.32% |
| 2006 | 107.21 Billion JPY | 6.05% |
| 2005 | 101.09 Billion JPY | 19.05% |
| 2004 | 84.92 Billion JPY | 24.58% |
| 2003 | 68.16 Billion JPY | 28.66% |
| 2002 | 52.98 Billion JPY | 20.7% |
| 2001 | 43.89 Billion JPY | -2.73% |
| 2000 | 45.12 Billion JPY | 30.1% |
| 1999 | 34.68 Billion JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 96.68 Billion JPY | 84.86% |
| 2023 Q2 | 64.12 Billion JPY | 29.5% |
| 2023 Q4 | 52.3 Billion JPY | 2.52% |
| 2023 FY | 296.64 Billion JPY | 41.15% |
| 2023 Q1 | 49.51 Billion JPY | -10.08% |
| 2023 Q3 | 51.01 Billion JPY | -20.44% |
| 2022 FY | 210.16 Billion JPY | 4.59% |
| 2022 Q1 | 54.33 Billion JPY | 16.8% |
| 2022 Q2 | 62.24 Billion JPY | 14.55% |
| 2022 Q3 | 39.45 Billion JPY | -36.62% |
| 2022 Q4 | 55.06 Billion JPY | 39.57% |
| 2021 Q1 | 84.47 Billion JPY | 1.8% |
| 2021 Q3 | 54.32 Billion JPY | 5.14% |
| 2021 Q4 | 46.52 Billion JPY | -14.36% |
| 2021 FY | 200.94 Billion JPY | 22.58% |
| 2021 Q2 | 51.66 Billion JPY | -38.83% |
| 2020 Q1 | 63.16 Billion JPY | -5.32% |
| 2020 Q3 | 83.58 Billion JPY | 11.7% |
| 2020 Q4 | 82.97 Billion JPY | -0.73% |
| 2020 FY | 163.93 Billion JPY | 10.97% |
| 2020 Q2 | 74.82 Billion JPY | 18.47% |
| 2019 Q1 | 76.16 Billion JPY | -1.95% |
| 2019 Q2 | 85.27 Billion JPY | 11.95% |
| 2019 Q3 | 74.95 Billion JPY | -12.1% |
| 2019 Q4 | 66.71 Billion JPY | -11.0% |
| 2019 FY | 147.71 Billion JPY | 0.91% |
| 2018 Q3 | 81.45 Billion JPY | 4.02% |
| 2018 Q1 | 74.18 Billion JPY | 3.61% |
| 2018 Q2 | 78.3 Billion JPY | 5.55% |
| 2018 Q4 | 77.68 Billion JPY | -4.63% |
| 2018 FY | 146.39 Billion JPY | -48.12% |
| 2017 Q2 | 71.4 Billion JPY | 7.86% |
| 2017 FY | 282.18 Billion JPY | 12.73% |
| 2017 Q4 | 71.6 Billion JPY | -1.89% |
| 2017 Q1 | 66.19 Billion JPY | 6.14% |
| 2017 Q3 | 72.98 Billion JPY | 2.22% |
| 2016 Q1 | 58.26 Billion JPY | -4.34% |
| 2016 Q2 | 65.63 Billion JPY | 12.64% |
| 2016 Q3 | 64.05 Billion JPY | -2.41% |
| 2016 FY | 250.31 Billion JPY | -1.65% |
| 2016 Q4 | 62.36 Billion JPY | -2.64% |
| 2015 Q2 | 68.02 Billion JPY | 9.73% |
| 2015 FY | 254.52 Billion JPY | 8.03% |
| 2015 Q4 | 60.9 Billion JPY | -4.25% |
| 2015 Q3 | 63.6 Billion JPY | -6.49% |
| 2015 Q1 | 61.98 Billion JPY | -21.2% |
| 2014 Q1 | 53.32 Billion JPY | -20.49% |
| 2014 Q2 | 57.91 Billion JPY | 8.6% |
| 2014 FY | 235.6 Billion JPY | 23.64% |
| 2014 Q3 | 56.76 Billion JPY | -1.98% |
| 2014 Q4 | 78.66 Billion JPY | 38.58% |
| 2013 FY | 190.54 Billion JPY | 10.77% |
| 2013 Q4 | 67.06 Billion JPY | 46.45% |
| 2013 Q3 | 45.79 Billion JPY | 12.72% |
| 2013 Q2 | 40.63 Billion JPY | 9.36% |
| 2013 Q1 | 37.15 Billion JPY | -14.67% |
| 2012 Q4 | 43.53 Billion JPY | 20.62% |
| 2012 Q1 | 49.58 Billion JPY | 32.16% |
| 2012 FY | 172.02 Billion JPY | 8.1% |
| 2012 Q2 | 42.89 Billion JPY | -13.49% |
| 2012 Q3 | 36.09 Billion JPY | -15.86% |
| 2011 FY | 159.13 Billion JPY | -2.18% |
| 2011 Q1 | 42.86 Billion JPY | 5.73% |
| 2011 Q2 | 42.12 Billion JPY | -1.72% |
| 2011 Q3 | 32.76 Billion JPY | -22.22% |
| 2011 Q4 | 37.52 Billion JPY | 14.5% |
| 2010 Q1 | 20.13 Billion JPY | 19.09% |
| 2010 FY | 162.67 Billion JPY | 154.54% |
| 2010 Q4 | 40.54 Billion JPY | 103.76% |
| 2010 Q3 | 19.89 Billion JPY | 6.02% |
| 2010 Q2 | 18.76 Billion JPY | -6.81% |
| 2009 FY | 63.91 Billion JPY | 8.15% |
| 2009 Q4 | 16.91 Billion JPY | -10.97% |
| 2009 Q3 | 18.99 Billion JPY | 1.54% |
| 2009 Q2 | 18.7 Billion JPY | 101.2% |
| 2009 Q1 | 9.29 Billion JPY | 15595.0% |
| 2008 Q4 | -60 Million JPY | -100.36% |
| 2008 Q3 | 16.68 Billion JPY | -19.03% |
| 2008 Q2 | 20.61 Billion JPY | -5.71% |
| 2008 Q1 | 21.85 Billion JPY | 21.02% |
| 2008 FY | 59.09 Billion JPY | -37.84% |
| 2007 Q4 | 18.06 Billion JPY | -34.39% |
| 2007 Q3 | 27.52 Billion JPY | 2.52% |
| 2007 Q1 | 22.64 Billion JPY | 0.0% |
| 2007 Q2 | 26.84 Billion JPY | 18.59% |
| 2007 FY | 95.07 Billion JPY | -11.32% |
| 2006 FY | 107.21 Billion JPY | 6.05% |
| 2005 FY | 101.09 Billion JPY | 19.05% |
| 2004 FY | 84.92 Billion JPY | 24.58% |
| 2003 FY | 68.16 Billion JPY | 28.66% |
| 2002 FY | 52.98 Billion JPY | 20.7% |
| 2001 FY | 43.89 Billion JPY | -2.73% |
| 2000 FY | 45.12 Billion JPY | 30.1% |
| 1999 FY | 34.68 Billion JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.16 Million USD | -30389517.083% |
| Ansell Limited | 129.3 Million USD | -273528.77% |
| Ansell Limited | 129.3 Million USD | -273528.77% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 31.13 Million USD | -1136131.746% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.59 Million USD | 22172298.927% |
| Psykey, Inc. | -797.5 Thousand USD | 44363764.634% |
| ConvaTec Group Plc | 262.7 Million USD | -134579.102% |
| ConvaTec Group Plc | 262.7 Million USD | -134579.102% |
| Encision Inc. | -640.78 Thousand USD | 55214111.608% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 249490262.894% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 321843090.994% |
| Innovative MedTech Inc. | -4.27 Million USD | 8277959.355% |
| LifePoint, Inc. | -7.49 Million USD | 4720463.41% |
| Medite Cancer Diagnostics, Inc. | -6.48 Million USD | 5460007.407% |
| Paradigm Medical Industries, Inc. | 330 Thousand USD | -107212627.273% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -122.89 Thousand USD | 287901475.214% |
| Reflect Scientific, Inc. | -467.27 Thousand USD | 75715626.945% |
| SmileDirectClub, Inc. | -241.15 Million USD | 146810.843% |
| Sector 10, Inc. | -39.84 Thousand USD | 887968175.494% |
| Shandong Weigao Group Medical Polymer Company Limited | 319.6 Million USD | -110599.15% |
| SheerVision, Inc. | 155.72 Thousand USD | -227195101.829% |
| United Health Products, Inc. | -2.42 Million USD | 14580619.827% |
| Vasamed, Inc. | 4.74 Million USD | -7460453.967% |
| Wearable Health Solutions, Inc. | -2.29 Million USD | 15422081.474% |
| Yubo International Biotech Limited | -1.2 Million USD | 29355829.189% |